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Family history of FXTAS is associated
with age‑related cognitive‑linguistic decline
among mothers with the FMR1 premutation
Jessica Klusek1* , Amanda Fairchild2, Carly Moser1, Marsha R. Mailick3, Angela John Thurman4 and
Leonard Abbeduto4

Abstract
Background: Women who carry a premutation allele of the FMR1 gene are at increased vulnerability to an array of
age-related symptoms and disorders, including age-related decline in select cognitive skills. However, the risk factors
for age-related decline are poorly understood, including the potential role of family history and genetic factors. In
other forms of pathological aging, early decline in syntactic complexity is observed and predicts the later onset of
neurodegenerative disease. To shed light on the earliest signs of degeneration, the present study characterized longitudinal changes in the syntactic complexity of women with the FMR1 premutation across midlife, and associations
with family history of fragile X-associated tremor/ataxia syndrome (FXTAS) and CGG repeat length.
Methods: Forty-five women with the FMR1 premutation aged 35–64 years at study entry participated in 1–5 longitudinal assessments spaced approximately a year apart (130 observations total). All participants were mothers of children with confirmed fragile X syndrome. Language samples were analyzed for syntactic complexity and participants
provided information on family history of FXTAS. CGG repeat length was determined via molecular genetic testing.
Results: Hierarchical linear models indicated that women who reported a family history of FXTAS exhibited faster
age-related decline in syntactic complexity than those without a family history, with that difference emerging as the
women reached their mid-50 s. CGG repeat length was not a significant predictor of age-related change.
Conclusions: Results suggest that women with the FMR1 premutation who have a family history of FXTAS may be at
increased risk for neurodegenerative disease, as indicated by age-related loss of syntactic complexity. Thus, family history of FXTAS may represent a personalized risk factor for age-related disease. Follow-up study is needed to determine
whether syntactic decline is an early indicator of FXTAS specifically, as opposed to being a more general age-related
cognitive decline associated with the FMR1 premutation.
Keywords: Grammatical complexity, Language production, Aging, Fragile X premutation
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Over 1 million individuals in the USA (1:151 females
and 1:468 men) are carriers of a premutation of the Fragile X Mental Retardation-1 (FMR1) gene, which occurs
when the FMR1 trinucleotide CGG sequence expands
to 55–200 repeats, compared to the normal range of ≤
40 repeats [1–3]. Female carriers of the FMR1 premutation can pass the problematic gene to their children,
which may cause fragile X syndrome, an inherited form
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of intellectual disability [4]. Carriers themselves can also
experience a substantially increased burden of disease,
which is thought to be mechanistically related to overexpressed FMR1 mRNA and associated mitochondrial
dysfunction and cell death that occurs in the FMR1 premutation [5–7]. Women with the FMR1 premutation
are at elevated risk for a variety of medical conditions,
including primary ovarian insufficiency [8, 9]; autoimmune, chronic pain, and endocrine disorders [10–14];
mental health disorders [12, 15–18]; executive dysfunction [19–22]; and increased expression of autism-related
traits such as reduced eye contact and social-communication difficulties [23–26]. Additionally, about 15% of
women with the FMR1 premutation will develop a lateonset neurodegenerative disease, fragile X-associated
tremor/ataxia syndrome (FXTAS), characterized by
ataxia, tremor, cognitive decline, and dementia [13, 27,
28]. Growing evidence, primarily gleaned from crosssectional data, also suggests that women with the FMR1
premutation may be vulnerable to premature age-related
decline in cognitive, executive, and language production
skills during midlife, although it remains unclear whether
these age-related changes represent precursors to FXTAS
or a more general decline in functioning associated with
the FMR1 premutation [19, 22, 29–31].
Because of the high prevalence of the FMR1 premutation in the general population and the increased disease
burden associated with the premutation, the delineation
of age-related phenotypes is crucial. At present, a major
barrier to the development of effective clinical management strategies is that nearly all evidence of age-related
change has been gleaned from cross-sectional data that
are insufficient for understanding longitudinal trajectories of the disease. Moreover, the risk factors that predispose individuals to age-related decline are poorly
understood. One potential risk factor that has not been
studied extensively is a family history of adverse phenotypes. In one preliminary study, women with the FMR1
premutation whose fathers experienced FXTAS reported
a higher prevalence of balance problems and menopausal symptoms compared to women whose fathers did not
experience FXTAS [32]. Thus, a positive family history of
FXTAS may place women with the FMR1 premutation at
increased clinical risk. However, there is a need to follow
up on these early findings using direct-assessment measures of clinical symptoms, given the reporting biases that
can occur with self-report. Gaining a better understanding of the family history of FXTAS as a factor that may
mark increased clinical risk is important for identifying
personalized risk factors that can be used to tailor counseling and prevention services. Additionally, the study of
the aggregation of clinical symptoms within families can
lead to a better understanding of etiology, including the
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effects of shared background genes and environmental
factors.
The identification of measures that are sensitive to
age-related phenotypes in the FMR1 premutation has
been a barrier to this work, as the earliest signs of neurodegeneration are subtle and difficult to capture with
traditional standardized measures of cognitive function,
self-reported symptoms, and even neurological examinations conducted by a movement disorder specialist [33].
Language sample analysis, which provides insight into
multiple dimensions of language production, is a method
that may prove useful in identifying age-related phenotypes in carriers of the FMR1 premutation. In other
forms of pathological aging, such as Alzheimer’s disease
and dementia, subtle language production deficits can be
observed early in disease progression before other cognitive deficits are able to be detected using traditional
standardized measures [34–36]. Language production is
supported by a wide range of cognitive processes, such
as semantic storage and retrieval as well as working
memory, executive control, and attention [37–39]. Thus,
the study of language production can provide a window
into “cognition in action” and can serve as an early and
sensitive indicator of age-related cognitive changes [36,
40–42].
A decrease in syntactic complexity is a strong predictor of the later onset of neurodegenerative disease in the
general population. Syntactic complexity refers to the
complexity of the grammatical structures within a sentence (for example, sentences can range from simple oneclause sentences to complex multi-clause sentences that
include multiple forms of embedding and subordination).
In healthy aging, syntactic complexity is relatively stable
through middle adulthood, with apparent decline generally not evident until the 70 s, corresponding to agerelated degradation of working memory [43–47]. Yet, in
pathological aging, such as in dementia and Alzheimer’s
disease, a decline in syntactic complexity is evident earlier in life and is a strong predictor of the later development of disease [46, 48–51]. In a landmark study focused
on the early autobiographical writings of a cloister of
nuns, the syntactic complexity of writings produced
when the nuns were young adults (mean age of 23 years)
predicted poorer cognitive function and the development
of Alzheimer’s disease more than 50 years later when the
nuns were evaluated again in old age and post-mortem
[52, 53]. Thus, diminished syntactic complexity is a sensitive risk marker for the development of neurogenerative
disease in late life.
In the present study, we examined syntactic complexity as a feature that may lend new insight into the earliest
manifestations of age-related cognitive decline in women
with the FMR1 premutation. Specifically, we sought to
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determine (a) whether women with the FMR1 premutation demonstrate age-related decline in syntactic complexity and (b) whether a family history of FXTAS and
CGG repeat length relate to age-related changes in syntactic complexity. We hypothesized that women with the
FMR1 premutation would exhibit a decline in syntactic
complexity across age, with the steepest decline observed
among those with a family history of FXTAS. We also
expected that the decline would be the most pronounced
among women with mid-range CGG repeat lengths, consistent with prior reports of curvilinear CGG risk patterns [19, 54, 55]. Understanding potential age-related
patterns of cognitive-linguistic decline in women with the
FMR1 premutation could assist with the identification of
women who are at the greatest risk for neurodegenerative
disease prior to the onset of obvious symptoms, allowing
for the implementation of prevention measures to prolong health in aging.

Methods
Participants

Participants were 45 women with the FMR1 premutation who were aged 35 to 64 years at study entry
(M = 47.20, SD = 7.50). All women were the biological mother to a child with fragile X syndrome (M age of
child = 17.78 years, SD = 6.32). Participants were drawn
from three larger studies that focused on language phenotypes associated with the FMR1 premutation or fragile X syndrome [26, 56]; these studies were linked and
followed mirrored protocols for data collection of all
variables of interest. The present study made use of a longitudinal convenience sample that represented a unique
opportunity to analyze age-related trajectory of syntactic complexity in mothers with the FMR1 premutation
across midlife. Participants completed 1–5 longitudinal
assessments (Mdn = 3, M = 2.9), for a total of 130 observations. The number of observations across participants
varied, given the inclusion of data drawn from multiple
studies. For example, seven participants contributed five
longitudinal observations, fifteen contributed four observations, four contributed three observations, four contributed two observations, and fifteen contributed one
observation. This variability in the number of observations was due to differences in the various study designs
of the larger projects from which participants were
drawn, rather than attrition.1 Assessments were spaced
approximately a year apart (M = 1.24 years, SD = 0.56).
All mothers spoke American English as their native
language and none had received a clinical diagnosis of

1

Inference across the presented models did not change when cases were
restricted to those with more than one data point.
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FXTAS, per participant report. The racial identity of the
sample was primarily White (91%) or Black (5%). The
reported educational level of participants was a high
school education or less (9%); some college (36%); a bachelor’s degree (33%); and a graduate degree (22%). FMR1
premutation status (55–200 CGG repeats on the 5’UTR
of FMR1) was confirmed through molecular genetic
testing. Recruitment methods included social media
posts targeted towards families of children with fragile
X syndrome, word of mouth, advertisements through
the National Fragile X Foundation, referrals from other
ongoing studies of fragile X syndrome being conducted
at the University of South Carolina [57], and outreach
through the IDDRC Research Participant Registry of the
University of North Carolina at Chapel Hill.
Procedures

Assessments were completed in a university laboratory
setting. The language assessment was the first behavioral
task administered in the protocol. The entire assessment
protocol, which included measures beyond those relevant
to the present study, lasted approximately 3 h. Questionnaires, including a demographic form inquiring about a
family history of FXTAS, were sent to participants about
two weeks prior to their appointment and were completed ahead of time. The Parenting Stress Index-4 Short
Form [58] and biospecimens for genetic analysis were
collected at a single time point and thus were treated as
time-invariant covariates in analyses. Biospecimens were
collected at the end of the study visit via either buccal
swab or blood sample. Participants were also provided
the option to have their blood drawn by their local physician at a time that was convenient for them. All participants provided informed consent and procedures were
approved by the Institutional Review Board of the University of South Carolina.
Measures
Syntactic complexity

Syntactic complexity was evaluated from language produced during the Five Minute Speech Sample [59], in
which participants were asked to talk about “what kind of
person their child is” and “how they get along” with their
child, for five minutes without any interjections from the
examiner. This sampling context is ideal for capturing
syntactic skills because the prompt elicits a spontaneous, uninterrupted spoken language sample of adequate
length to ensure stability of analyses and has been used
for similar purposes in previous work [30, 54, 60]. The
ensuing data were transcribed using the conventions
of Systematic Analysis of Language Transcripts [61] by
research assistants who were trained to > 80% inter-rater
agreement on morphemes and utterance segmentation
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on three consecutive training files. Inter-rater reliability conducted by an independent transcriber on 20% of
randomly selected transcripts was at 98% for morphememorpheme agreement and 84% for the segmentation of
utterances into C-units.
Syntactic complexity was evaluated from the transcripts using Coh-Metrix 3.0 [62], a computational linguistics and discourse processing software that integrates
a variety of natural language processing tools to analyze
texts, including part-of-speech taggers [63], lexicons,
syntactic parsers, latent semantic analysis, and pattern classifiers [64]. Although a variety of different metrics have been used in prior research to index syntactic
complexity (e.g., counts of left-branching clauses, handscoring methods such as IPSYN), the use Coh-Metrix
has implementation advantages given it does not require
specialized software, programming expertise, or laborious hand-coding or tagging. The syntactic simplicity Z
score (“PCSYNz”) was used as an index of the complexity
of syntactic structures. This score is a principal component-derived text complexity index based on the analysis
of over 37,500 texts spanning thirteen grade levels and
various genres [65, 66]. The syntactic simplicity Z score
indicates the degree to which the sentences contain fewer
words and use simpler syntactic structures as reflected by
the number of words per sentence, the number of words
before the main verb, the ratio of function words to content words, the number of words per sentence, and the
syntactic similarity across sentences [66]. To facilitate
interpretation, the sign of the syntactic simplicity Z score
was reversed so that a higher score denoted greater syntactic complexity.
Family history of FXTAS

Information on the family history of FXTAS was collected as part of a standard demographic questionnaire.
Participants responded “yes” or “no” to the question “Has
anyone in your family been diagnosed with FXTAS?”. A
blank space was provided for participants who responded
“yes” to provide information about their relationship to
the diagnosed relative. This information was collected
at each assessment. If a new FXTAS case in the family
emerged as the study progressed, that family history was
considered positive for all preceding time points.
FMR1 CGG repeat number

CGG repeat DNA analysis was conducted as part of the
larger studies from which the present sample was drawn.
Specifically, these data derive from the MIND Institute
at the University of California Davis Health (54% of samples), Rush University Medical Center (25% of samples),
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and the New York State Institute for Basic Research in
Developmental Disabilities (21% of samples). CGG repeat
size analysis of the 5′-UTR of FMR1 was conducted on
DNA derived from peripheral blood lymphocytes (Qiagen, Valencia, CA), whole blood dried blood spots [67],
or buccal swabs. Polymerase chain reaction (PCR) amplification of the FMR1 CGG repeat region was conducted
with AmplideX® FMR1 PCR (RUO) reagents (Asuragen,
Austin, TX 78,744 USA). PCR products were analyzed by
capillary electrophoresis and GeneMapper software for
FMR1 allele CGG repeat sizing (ABI 3130 Genetic Analyzer, Applied Biosystems, Foster City, CA) [68]. Inter-lab
reliability was evaluated on 24% of samples, where seven
participants submitted samples to two of the labs and
three participants submitted samples to all three labs.
Intraclass correlation coefficients (ICC [1, 3]) indicated
excellent reliability at 0.97 across the labs.
Covariates

Education level was collected via a standard demographic form and coded as a four-level categorical variable: ≤ high school, some college, bachelor’s degree, some
graduate school or higher. This variable was included as
a covariate because educational attainment is thought to
represent a neuroprotective factor against the development of dementia [69] and is also associated with some
measures of verbal output, such as mean length of utterance [70]. The Parenting Stress Inventory-4 Short Form
(PSI-4 SF; [58]) was also collected as a covariate, given
the high levels of parenting stress experienced by mothers with the FMR1 premutation [71], and the understanding that stress may contribute to vulnerability in normal
and pathological aging [72]. The PSI-4 SF is a 32-item
questionnaire that captures child, parent, and situational/
demographic characteristics that contribute to parenting
stress. This scale shows good test–retest reliability of 0.84
over 6 months, high internal consistency (α = 0.94), and
high concordance when validated against the full length
PSI-4 [58]. Internal consistency in the present sample
was (α = 0.91). The Total Stress percentile score was used
in analyses.
Data analysis

Analyses were conducted in SAS v9.4 (SAS Institute,
2013). First, descriptive statistics were computed and
the variables examined for normal distribution. One
case exhibited a value for the syntactic complexity variable that was an extreme outlier (3.10) relative to both
the sample as a whole, as well as to the other longitudinal
datapoints for that case and was thus top-coded to 1.73
(a value slightly above the next highest observation in
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the sample; 1.72). Top-coding allowed for a normal distribution of the syntactic complexity outcome and also
minimized undue influence of this extreme outlier on the
models.2 Across all statistical models, age was centered at
50 years, total parenting stress percentile score was centered at the mean of 58, and CGG repeat length was centered at the mean of 97.
To address the research questions, a series of random
intercept, hierarchical linear models (HLMs) were fit
using PROC MIXED. In line with contemporary methodological recommendations, a model-building approach
was used where an unconditional means model was first
considered to provide a null baseline model. Several
more gradually complex models were then estimated to
consider the influence of various predictors of interest, in
line with each research question [73]. At each step, the
Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) deviance-based statistics were
examined to evaluate overall improvement in model fit.
All models were estimated with maximum likelihood
estimation, which is a contemporary approach to handle
missing data that uses all available information on each
variable to optimize the overall likelihood function of the
data while yielding unbiased parameter estimates [74].
Unstructured covariance matrices were specified to allow
variance components to be freely estimated. Denominator degrees of freedom were calculated using the Kenwood-Roger approximation [75]. Chronological age was
nested within participant as the marker of change over
time. The parenting stress and genetic variables were
treated as time-invariant in the statistical models.
To investigate the first research question on change in
syntactic complexity across age, the fixed effect of age
was added as a predictor and fit was compared to the
null, baseline model. Fixed effects for education level
and parenting stress were added in a third model, but
deviance-based model fit statistics did not indicate any
improvement in model fit and neither variable accounted
for significant variance. Therefore, the more parsimonious model (with only the fixed effect age added over baseline) was selected as the final model for the first research
question. To address the second research question on the
relationship of family history of FXTAS to syntactic complexity, the fixed effect of FXTAS family history (positive/negative family history) and the interaction between
family history and age were added as predictors, and
improvement in model fit was evaluated against the main
effect of age model. Next, fixed effects for education level
and parenting stress were incorporated and considered in
2

Sensitivity analyses indicated that the inference across the models was the
same regardless of whether the influential point was retained, omitted, or topcoded.
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Table 1 Descriptive statistics at study entry
Variable

M (SD)
Range

Syntactic complexity Z score, Coh-Metrix
M (SD)

0.74 (0.58)

Range

− 0.18–3.10

Total stress percentile, Parenting Stress Index-4 Short Form
M (SD)

62.00 (20.38)

Range

4.00–94.00

CGG repeat length
M (SD)

96.82 (18.08)

Range

64.00–170.00

Education level, n (%)
High school education or less

16 (36%)

Some college

15 (33%)

Bachelor’s degree

4 (9%)

Graduate degree

10 (22%)

the model-building process. Deviance-based fit statistics
did not support the inclusion of education level or parenting stress variables in the model, however, and neither
variable accounted for significant variance. Thus, these
covariates were not included in the final model.
The final research question on the relationship
between CGG repeat length and syntactic complexity
was addressed using a similar model-building process in
which a series of random intercept HLMs were considered. An unconditional means model was first estimated.
Then a model including the fixed effects of age and linear CGG repeat length was estimated and overall model
fit was compared to the unconditional, baseline model.
Finally, two nonlinear models that considered the interaction between age and CGG and the quadratic effect of
CGG were estimated and evaluated, respectively [19, 54,
55]. In addition to the continuous CGG analyses, models were also run using a categorical CGG variable, with
CGG length coded as low (55–89), mid-size (90–110),
and high (111–200) categories, consistent with prior
reports (Allen et al., 2007; Mailick et al., 2014; Sullivan
et al., 2005). An analogous model-building approach was
employed for this variant of the data, with unconditional
baseline, main effect, and interactive models estimated
and compared as they were for the continuous CGG
variable. As with the first and second research questions,
education level and parenting stress were probed as
covariates in the models evaluated for the final research
question, as were the interactions involving CGG, education, and parenting stress. Deviance-based fit statistics
did not support the inclusion of either variable or their
interaction with CGG in the model. Thus, these covariates were not retained in the final models.
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Table 2 Descriptive statistics by family history of FXTAS
Variable

Family History of FXTAS
Negative (n = 33)

Positive (n = 12)

Total number of observations

90

40

Observations per participant, M (SD)

2.73 (1.63)

3.33 (1.30)

Age at entry (years), M (SD)

46.88 (7.27)

48.10 (8.31)

Syntactic complexity Z score, Coh-Metrix, M (SD)

0.69 (0.45)

0.88 (0.86)

Total stress percentile, Parenting Stress Index-4, M (SD)

62.84 (20.76)

59.83 (20.08)

CGG repeat length, M (SD)

96.30 (19.41)

94.14 (14.46)

Education level, n (%)
High school education or less

13 (39%)

3 (25%)

Some college

9 (27%)

6 (50%)

Bachelor’s degree

3 (9%)

1 (8%)

Graduate degree

8 (24%)

2 (17%)

Results
Descriptive statistics

Table 1 displays descriptive statistics of the sample at
study entry. Twelve participants reported a positive
family history of FXTAS. Of these, the majority (75%)
reported that the family member who had received a
diagnosis of FXTAS was their father. Of the remaining
individuals, two participants did not indicate which family member was affected and one reported their brother
as the affected family member.3 Participants with a positive family history of FXTAS (n = 12) contributed 40 longitudinal observations and those with a negative family
history (n = 33) contributed 90 longitudinal observations.
The subgroups with and without positive family histories
of FXTAS did not differ in age at study entry (p = 0.633),
age averaged across all observations (p = 0.181), or in
the number of observations per individual (p = 0.252).
Table 2 shows descriptive statistics across the two subgroups at study entry.
To describe the presence of motor symptoms potentially linked to FXTAS, scores on the Tremor Disability
Questionnaire [76] were examined descriptively across
the two subgroups at study exit. This self-report questionnaire assesses difficulty completing daily activities
due to tremor (e.g., zipping a zipper, typing shoes), with
difficulty completing each activity rated on a scale of
“0” (no problem), “1” (reduced efficiency), or “2” (need
to modify was task is performed; task is difficult). Total
scores range from 0 to 60. There were no differences in
self-reported functional tremor symptoms across the
family history subgroups (p = 0.806), with a mean score
3

To explore the impact of affected family member, sensitivity analyses were
conducted by omitting the three participants who did not specify their
father as the family member affected by FXTAS. Inference across all models
remained the same.

of 1.28 (SD = 3.78) in those without a family history and
of 1.58 (SD = 3.20) in those with a family history. Therefore, functional tremor symptoms were low overall and
did not appear to be elevated among the participants
with a family history of FXTAS.
Age‑related stability of syntactic complexity

Results indicated that, as a group, mothers with the
FMR1 premutation did not exhibit significant changes
in syntactic complexity across age (p = 0.292). Model
results are presented in Table 3. However, when age
and family history of FXTAS were considered together,
results indicated that these factors interacted to
affect syntactic complexity (p = 0.006; see Table 4),
such that those who had a positive family history of
FXTAS exhibited faster decline in syntactic complexity across age relative to those without a history of
FXTAS in their family (see Fig. 1). For every year of
time, on average, mothers with a positive family history of FXTAS showed a 0.05 decrease in the syntactic
complexity Z score relative to those without a positive
family history. Bonferroni-corrected post-hoc analyses
Table 3 HLM testing age-related change in syntactic complexity
Estimate (SE)

p

Fixed effects
Intercept

0.59 (0.06)

< 0.001*

Age

− 0.01 (0.01)

0.292

Error variance
Level-1

0.16 (0.02)

< 0.001*

Intercept

0.08 (0.03)

0.009*

Notes. Estimation method = maximum likelihood; Kenwood-Roger degrees of
freedom. AIC = 177.7. BIC = 184.4
*p < 0.050.
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Table 4 HLM testing age-related change in syntactic complexity
by family history of FXTAS
Estimate (SE)

p

Fixed effects
Intercept

0.64 (0.07)

< 0.001*

Age

0.01 (0.01)

0.383

Group

− 0.10 (0.12)

0.398

Group*age
Error variance

− 0.05 (0.02)

0.006*

Level-1

0.16 (0.02)

< 0.001*

Intercept

0.06 (0.03)

0.011*

Notes. Estimation method = maximum likelihood; Kenwood-Roger degrees of
freedom. AIC = 173.6. BIC = 183.8
*p < 0.050
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Relationship between CGG repeat length and age‑related
stability of syntactic complexity

CGG repeat length was not a significant predictor of agerelated change in syntactic complexity either when tested
as a continuous linear, quadratic variable, or as a categorical variable, and statistical inferences regarding all
fixed and random coefficients were consistent across the
models. Deviance statistics indicated that the model with
the continuous linear CGG term was the best fit among
the set and thus results for that parameterization are provided here (see Table 5).

Discussion
Decline in syntactic complexity is a strong predictor of
the later onset of neurodegenerative disease. Through

Fig. 1 Age-related change in syntactic complexity by family history of FXTAS

testing group differences in syntactic complexity at 40,
45, 50, 55, and 60 years of age indicated group differences were evident at 55 years old (t[58.7] =  − 2.16,
p = 0.037) and 60 years of age (t[58.7] =  − 2.63,
p = 0.012), but were not significantly different at
younger ages: 50 years(t[58.7] =  − 0.86, p = 0.398),
45 years (t[58.7] = 0.97, p = 0.339), or 40 years of age
(t[58.7] = 1.95, p = 0.059).

the analysis of longitudinal language samples collected
from mothers who carry the FMR1 premutation, the
present study suggests that age-related decline in syntactic complexity may be accelerated among individuals who have a history of FXTAS in their family. Thus,
this study sheds light on family history of FXTAS as
a personalized risk factor that appears to increase
risk for pathological aging in mothers with the FMR1

Klusek et al. Journal of Neurodevelopmental Disorders

(2022) 14:7

Table 5 HLM testing CGG repeat as a predictor of age-related
change in syntactic complexity
Estimate (SE) p
Continuous CGG model (linear) Fixed effects
Intercept

0.56 (0.06)

Age

− 0.01 (< 0.01) 0.502

CGG
CGG*age

< 0.001*

< 0.01 (< 0.01) 0.547
< 0.01 (< 0.01) 0.933

Error variance
Level-1

0.16 (0.03)

< 0.001*

Intercept

0.07 (0.03)

0.009*

Notes. Estimation Method = maximum likelihood; Kenwood-Roger degrees of
freedom. AIC = 178.2. BIC = 189.1
*p < 0.050

premutation. This information could be useful in the
development of methods to target prevention and
detection efforts to those who are at heightened risk
for age-related disease. Preserving health with age is
particularly meaningful within the context of fragile X syndrome because mothers who carry the FMR1
premutation often continue to provide daily care and
assistance for their children with fragile X syndrome
throughout midlife.
As a group, mothers with the FMR1 premutation did
not exhibit a decline in syntactic complexity across
midlife. This suggests that vulnerability to neurodegenerative disease, as reflected by diminished syntactic
complexity, was not generalized across all mothers with
the FMR1 premutation. However, results indicated that
mothers who have a history of FXTAS in their family may
be particularly vulnerable. On average, participants who
had a relative with FXTAS showed a 0.05 decrease in the
syntactic complexity Z score for each year passed relative
to those without a diagnosed relative. Although research
on family history of FXTAS as a risk factor is sparse,
our results are consistent with, and extend through an
objective measure, those of Chonchaiya et al. [32], who
found that women whose fathers had FXTAS were more
likely to report balance and menopausal symptoms than
women whose fathers did not have FXTAS. Thus, across
these two independent reports and both self-report and
direct-assessment measures, there is converging evidence
that women with the FMR1 premutation who have a family history of FXTAS may be at elevated risk for clinical
involvement. The functional impact of the declining syntactic complexity observed in the present study is unclear,
although this type of language production difficulty can
be perceived by patients as “word finding problems” or
“brain fog” [77], both of which have been reported anecdotally by women with the FMR1 premutation.
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It is notable that the difference related to family history
of FXTAS did not emerge until older ages. The syntactic complexity of the mothers with a positive family history of FXTAS did not diverge from that of those with a
negative family history until the mothers reached their
mid-50 s. The finding of age effects is consistent with
prior cross-sectional analyses indicating that older age is
correlated with increased severity of various symptoms
in women with the FMR1 premutation [19, 29, 30]. The
present study contributes to the scant longitudinal data
on the FMR1 premutation, bolstering the hypothesis that
the expression of certain aspects of the FMR1 premutation phenotype are modulated by age.
Future directions of this work could include investigation of potential interactions with other age-related
aspects of the FMR1 premutation phenotype, such as
early menopause associated with fragile X-associated
primary ovarian insufficiency (FXPOI). It is unclear
from the present literature whether reduced syntactic
complexity is associated with menopause. However, a
potential link is plausible given that other cognitive-linguistic skills, such as verbal fluency, appear to be negatively related to menopause [78–80]. Chonchaiya et al.
[32] reported increased menopausal symptoms in women
whose fathers had FXTAS, and therefore, it is possible
that the syntactic complexity decline in those with a family history of FXTAS could be related to hormonal differences occurring within this subgroup. This hypothesis
should be explored in future research.
Given that prior research has shown that diminished
syntactic complexity is linked with neurodegenerative
diseases such as Alzheimer’s disease and dementia, it is
possible that the decline in syntactic complexity observed
in the present study marks vulnerability for age-related
neurodegeneration of some type [46, 48–51]. Additional
research is needed to determine whether the observed
decline in syntactic complexity marks vulnerability for
FXTAS specifically or for more generalized premutation-associated neurodegeneration that is distinct from
FXTAS. Additionally, the mechanisms by which family history of FXTAS is associated with loss of syntactic
complexity are yet unknown and should be explored in
future research. Regardless, the results of this study do
suggest that mothers who have a family history of FXTAS
may be at increased risk for pathological aging. This
raises questions about pathologic processes associated
with FXTAS that may be shared within families, beyond
CGG repeat length. It is possible that the familial risk
patterns observed here may reflect a common set of secondary genetic or other vulnerabilities that predispose
the participants and their family members to FXTAS.
For example, the APOE ε4 allelotype is a genetic risk factor for dementia-producing diseases that also appears to
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influence FXTAS risk [81]. Environmental risk factors
may also be more likely to be shared among relatives.
The present study examined education level as an environmental factor that might relate to age-related decline
in syntactic complexity, but no relationship was detected.
Future studies may explore other factors that may be
shared within families and have been linked to risk for
neurodegenerative disease, including diet, physical activity, access to healthcare, and vascular disease [82–85].
Adopting a family design in future studies may be helpful
in identifying the mechanisms that contribute to risk for
developing FXTAS within families.
Although preliminary, the present study has potential
clinical implications that may pave the way for future
research. It is common for women with FMR1 premutation who have seen a family member experience FXTAS
to express concerns about their own risk for health
problems as they get older. Counseling and prevention
efforts for these women have been hampered by poor
understanding of risk factors for age-related symptom
aggravation, including the role of family history. While
the clinical implications from this study are preliminary,
findings suggest that mothers with a family history of
FXTAS may be at increased risk for age-related decline
relative to those without a family history. Clinical monitoring, particularly as individuals reach late midlife,
may be useful in establishing baseline performance and
detecting the early signs of degeneration. It may also be
advisable to take a more proactive approach to prevention, given that it is known that about 15% of women with
the FMR1 premutation will develop FXTAS [13, 27] and
many others will experience increased symptom expression with age, regardless of FXTAS status [19, 22, 29–31].
There are several modifiable factors that can be targeted
to preserve cognitive health with aging, such as exercise,
smoking cessation, maintaining social engagement, and
clinical management of medical problems like hypertension and depression [86, 87]. It is likely that these factors
would also promote healthy aging within the context of
the FMR1 premutation. Stress management may also be
particularly important for mothers with the FMR1 premutation, who experience high levels of parenting stress
and may experience increased risk as a consequence [16,
71, 88, 89].
The present study also has numerous strengths. One
notable strength is the use of a longitudinal design,
which allowed us to model change within the same
cohort of individuals across time. Most prior studies
of age-related change in the FMR1 premutation have
relied on cross-sectional data, which provide only a
snapshot into time and are insufficient for delineating longitudinal trajectories. Another advantage of the
use of a repeated measures design is that it requires
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fewer participants to achieve statistical power relative
to a between-participants design, as it allows researchers to disentangle variance due to individual differences from error variance in the model. Thus, although
participants with a positive family history of FXTAS
consisted of a relatively small subgroup of 12 participants, these participants contributed a total of 40 longitudinal observations to analysis. Future replication in
larger samples will inform generalizability across more
nuanced dimensions not examined here, such as variation related to background gene effects or environmental factors (e.g., diet, smoking).
Another strength is the use of automatic language processing software, Coh-Metrix, to index syntactic complexity. Although a variety of other methods for indexing
syntactic complexity exist, the implementation advantages of automated natural language processing software
are substantial because this method does not require
programming expertise or time-consuming hand-coding
or tagging. Such an approach could be easily scalable
for potential clinic-based applications in the future. For
example, modern automated transcription and language
processing software would allow patients to provide a
brief language sample that could be transcribed and analyzed for syntactic complexity within minutes, making it
feasible to monitor changes in syntactic complexity during routine check-ups. Our focus on syntactic complexity
is also a strength, given the strong connection between
the reduced syntactic complexity and the later development of neurodegenerative disease in other populations,
as well as evidence that language production deficits represent some of the earliest detectable signs of disease,
sometimes emerging before other cognitive deficits are
able to be detected using traditional standardized measures [34–36]. Because this study capitalized on a rare
corpus of longitudinal language samples from women
with the FMR1 premutation originally gathered for other
purposes, we did not have access to other measures of
neuropsychological performance to complement the
cognitive-linguistic data. The inclusion of cognitive test
performance measures in future work could inform the
cognitive factors that relate to the loss of syntactic complexity within women with the FMR1 premutation. Likewise, we did not have access to FXTAS outcome data on
the participants themselves and therefore cannot draw
conclusions as to whether the observed decline in syntactic complexity reflects general neurodegeneration associated with the FMR1 premutation genotype versus risk for
FXTAS specifically. Finally, the inclusion of other FMR1related indices in future work, such as messenger RNA,
Fragile X Mental Retardation Protein, or information on
mosaicism or activation ratio, would also enhance understanding of potential FMR1 associations beyond CGG.
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Our use of participant self-report data to evaluate
FXTAS family history is a limitation. Direct assessment
of FXTAS in family members would have been more
reliable, as we cannot rule out the possibility that a relative had FXTAS that had yet to be clinically identified.
Another limitation of relying on participant report is that
this method assumes that the participant is informed of
their extended family members’ medical problems. Additionally, because of the late onset of FXTAS, it is possible that some participants will have a family member
develop FXTAS in the future. The challenge of an incomplete observation period could have resulted in the inclusion of some individuals in the “negative family history”
subgroup who may eventually go on to have a relative
diagnosed with FXTAS, which could have attenuated the
observed effects.
Regarding the sample, it also should be noted that all
participants were mothers caring for a child with fragile X
syndrome, and therefore, caution is needed when generalizing patterns to the broader population of women with the
FMR1 premutation. Studies aimed at understanding FMR1
premutation-associated risk as manifested in mothers
of children with fragile X syndrome are highly important
because clinical problems in mothers impact outcomes for
both the mother and her children. However, mothers with
the FMR1 premutation represent a subgroup of individuals who, on average, will show higher CGG repeat lengths
than the broader population of females with the FMR1 premutation [90] and may be at heightened risk for FXTAS
and the expression of other premutation-associated phenotypes as a result. Mothers of children with fragile X
syndrome also experience high levels of parenting stress
which is also associated with increased vulnerability for
symptom expression [16, 71, 88, 89]. In this study, neither
parenting stress, indexed via the PSI-4 SF, nor the interaction between parenting stress and CGG repeat length were
significant predictors of syntactic complexity in any of our
analyses. However, follow-up studies are needed to obtain a
more comprehensive understanding of the potential impact
of parenting a child with fragile X syndrome on age-related
patterns, including the inclusion of more varied indices of
objective and subjective stress and indicators of child disability severity. Potential CGG-stress interactions should be
pursued in future research with larger samples, as we may
have been underpowered to detect such an effect. Additionally, our focus on mothers of children with fragile X
syndrome may have resulted in ascertainment bias of participants who were more intimately familiar with the effects
of fragile X syndrome within families and the full spectrum
of fragile X-associated conditions, including FXTAS. If so,
this may be viewed as a weakness (decreased generalizability to the larger population) or a strength (knowledge
of fragile X-associated conditions may have been enhanced

Page 10 of 13

the validity of the FXTAS variable in this study). Finally, it
should be noted that the participants enrolled in this study
were primarily of White racial identity, which is a limiting factor in generalizing findings to the larger population
of individuals with the FMR1 premutation. Inadequate
minority representation in participant samples remains a
challenge in research involving neurodevelopmental disorders [91], including fragile X syndrome [92], and should be
explicitly addressed in future work.
In conclusion, the results of the present study suggest that family history of FXTAS may be associated with
heightened risk for neurodegenerative disease, as marked
by accelerated age-related decline in syntactic complexity.
Thus, the present study sheds light on the family history
of FXTAS as a potential personalized risk factor that could
prove useful for identifying those who are most at risk to
better target prevention efforts, potentially even before the
onset of symptoms. Preserving the health of mothers with
the FMR1 premutation as they age is important for both
the outcomes of the mothers and for their children with
fragile X syndrome.
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